Darrel P. Cohen

Primary and Secondary Kinase Genotypes Correlate With the Biological and Clinical Activity of Sunitinib in Imatinib-Resistant Gastrointestinal Stromal Tumor

Michael C. Heinrich, Robert G. Maki, Christopher L. Corless et al. · Journal of Clinical Oncology · 2008 · 806 citations · Full text

Medicine, Oncology, Pharmacology +17

Complete Longitudinal Analyses of the Randomized, Placebo-Controlled, Phase III Trial of Sunitinib in Patients with Gastrointestinal Stromal Tumor following Imatinib Failure

George D. Demetri, Christopher R. Garrett, Patrick Schöffski et al. · Clinical Cancer Research · 2012 · 136 citations · Full text

Medicine, Oncology, Pharmacology +15

Molecular Target Modulation, Imaging, and Clinical Evaluation of Gastrointestinal Stromal Tumor Patients Treated with Sunitinib Malate after Imatinib Failure

George D. Demetri, Michael C. Heinrich, Jonathan A. Fletcher et al. · Clinical Cancer Research · 2009 · 133 citations · Full text

Medicine, Oncology, Pharmacology +17

Sunitinib-associated hypertension and neutropenia as efficacy biomarkers in metastatic renal cell carcinoma patients

Frede Donskov, M. Dror Michaelson, Igor Puzanov et al. · British Journal of Cancer · 2015 · 99 citations · Full text

Medicine, Oncology, Pharmacology +17

Hypertension as a potential biomarker of efficacy in patients with gastrointestinal stromal tumor treated with sunitinib

Suzanne George, Peter Reichardt, T. Lechner et al. · Annals of Oncology · 2012 · 84 citations · Full text

Medicine, Oncology, Pharmacology +14